Breaking Class Action News & Legal Updates

Bayer continues to shell out settlement compensation to those affected by allegedly serious blood clotting complications suffered as a result of Yaz and Yasmine use.

The FDA has ordered GlaskoSmithKline to add the risk of potentially fatal heart arrhythmia to the warning label of chemotherapy side effect treatment drug Zofran.

A new study has once again shown rare atypical femoral fractures in women share a link with the osteoporosis drug Fosamax, a drug taken to improve bone density.

A new Canadian study of 115,000 patients treated with the diabetes drug confirmed Actos can double the risk of bladder cancer.

Nearly 1,500 women have signed an online petition meant to help create awareness for the serious health problems associated with the intrauterine device Mirena.

Facebook is reportedly in the crosshairs of several class actions alleging the social media giant misled shareholders and illegally tracked its web users.

An FDA advisory group will thoroughly investigate the pros and risks associated with controversial metal-on-metal hip implants June 27 and 28.

The NJ-based pharmaceutical giant has reserved $600 million to potentially settle lawsuits alleging the company paid Omnicare to buy more lots of schizophrenia drugs.

Corrosion issues in Chrysler's Jeep Liberty's SUVs has lead to a recall.